{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:38:00Z","timestamp":1792190280940,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"FCT","award":["SFRH\/BD\/41536\/2007"],"award-info":[{"award-number":["SFRH\/BD\/41536\/2007"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ejpb.2013.12.004","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T18:16:51Z","timestamp":1386785811000},"page":"133-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: In vitro vs. in vivo studies"],"prefix":"10.1016","volume":"86","author":[{"given":"Carla","family":"Vitorino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lamarche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Gobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Couet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2013.12.004_b0235","series-title":"Transdermal and Topical Drug Delivery","first-page":"1","article-title":"Skin structure, function, and permeation","author":"Benson","year":"2011"},{"key":"10.1016\/j.ejpb.2013.12.004_b0010","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.addr.2003.10.028","article-title":"Lipid vesicles and other colloids as drug carriers on the skin","volume":"56","author":"Cevc","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2013.12.004_b0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2012.09.017","article-title":"Approaches for breaking the barriers of drug permeation through transdermal drug delivery","volume":"164","author":"Alexander","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2013.12.004_b0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2013.02.011","article-title":"Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail","volume":"167","author":"Vitorino","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2013.12.004_b0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2008.08.040","article-title":"Microneedle mediated delivery of nanoparticles into human skin","volume":"366","author":"Coulman","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2013.12.004_b0030","article-title":"Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin","volume":"6","author":"Kumar","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2013.12.004_b0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine: pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2013.12.004_b0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.12.487","article-title":"Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1","volume":"101","author":"Meyer","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejpb.2013.12.004_b0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/j.2051-5545.2009.tb00199.x","article-title":"Metabolic syndrome in people with schizophrenia: a review","volume":"8","author":"De Hert","year":"2009","journal-title":"World Psychiat."},{"key":"10.1016\/j.ejpb.2013.12.004_b0050","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1517\/14656566.5.12.2583","article-title":"Simvastatin: a review","volume":"5","author":"Pedersen","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejpb.2013.12.004_b0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1527-3466.2008.00047.x","article-title":"Simvastatin: two decades in a circle","volume":"26","author":"Kolovou","year":"2008","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ejpb.2013.12.004_b0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10717540500455975","article-title":"Dermal and transdermal drug delivery systems: current and future prospects","volume":"13","author":"Brown","year":"2006","journal-title":"Drug Delivery"},{"key":"10.1016\/j.ejpb.2013.12.004_b0065","first-page":"117","article-title":"Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery","volume":"5","author":"Lin","year":"2010","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2013.12.004_b0070","article-title":"Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles","author":"Venishetty","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejpb.2013.12.004_b0075","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/jps.20100","article-title":"Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers","volume":"93","author":"Wong","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2013.12.004_b0245","series-title":"Pharmaceuticals, Body Fluids and Postmortem Material","article-title":"Clarke\u2019s analysis of drugs and poisons","author":"Moffat","year":"2004"},{"key":"10.1016\/j.ejpb.2013.12.004_b0085","unstructured":"Olanzapine \u2013 Compound Summary. <http:\/\/pubchem.ncbi.nlm.nih.gov\/summary\/summary.cgi?cid=4585> (accessed 16.05.13)."},{"key":"10.1016\/j.ejpb.2013.12.004_b0090","unstructured":"Simvastatin \u2013 Compound Summary. <http:\/\/pubchem.ncbi.nlm.nih.gov\/summary\/summary.cgi?cid=54454&loc=ec_rcs> (accessed 16.05.13)."},{"key":"10.1016\/j.ejpb.2013.12.004_b0095","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jaoac\/93.3.811","article-title":"Development and validation of an HPTLC method for determination of olanzapine in formulations","volume":"93","author":"Patel","year":"2010","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.ejpb.2013.12.004_b0100","article-title":"20Years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications","author":"M\u00fcller","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.ejpb.2013.12.004_b0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.colsurfb.2010.12.024","article-title":"The size of solid lipid nanoparticles: an interpretation from experimental design","volume":"84","author":"Vitorino","year":"2011","journal-title":"Colloids Surf., B: Biointerf."},{"key":"10.1016\/j.ejpb.2013.12.004_b0110","unstructured":"ISO13321, Methods for Determination of Particle Size Distribution Part 8: Photon Correlation Spectroscopy, International Organisation for Standardisaton (ISO), 1996."},{"key":"10.1016\/j.ejpb.2013.12.004_b0115","unstructured":"ISO22412, Particle Size Analysis \u2013 Dynamic Light Scattering, International Organisation for Standardisation (ISO), 2008."},{"key":"10.1016\/j.ejpb.2013.12.004_b0120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2009.01.014","article-title":"Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery","volume":"372","author":"Lv","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2013.12.004_b0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0731-7085(00)00309-5","article-title":"Direct-injection LC\u2013MS\u2013MS method for high-throughput simultaneous quantitation of simvastatin and simvastatin acid in human plasma","volume":"23","author":"Jemal","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2013.12.004_b0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2008.06.028","article-title":"Development of SLNs from natural lipids: application to topical delivery of tretinoin","volume":"363","author":"Mandawgade","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2013.12.004_b0135","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1128\/AAC.00411-10","article-title":"Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats","volume":"54","author":"Marchand","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2013.12.004_b0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejpb.2008.11.013","article-title":"Non-invasive in vivo methods for investigation of the skin barrier physical properties","volume":"72","author":"Darlenski","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2013.12.004_b0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpba.2005.01.016","article-title":"Application of a novel ultra-low elution volume 96-well solid-phase extraction method to the LC\/MS\/MS determination of simvastatin and simvastatin acid in human plasma","volume":"38","author":"Yang","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2013.12.004_b0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jconrel.2004.10.005","article-title":"In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs","volume":"102","author":"Valiveti","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2013.12.004_b0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpb.2004.02.015","article-title":"Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations","volume":"58","author":"Souto","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2013.12.004_b0160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.colsurfa.2007.06.003","article-title":"Preparation and characterization of monocaprate nanostructured lipid carriers","volume":"311","author":"Lin","year":"2007","journal-title":"Colloids Surf., A: Physicochem. Eng. Aspects"},{"key":"10.1016\/j.ejpb.2013.12.004_b0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-3659(03)00033-6","article-title":"Comparison of dissolution profiles of Ibuprofen pellets","volume":"89","author":"Costa","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2013.12.004_b0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2013.12.004_b0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2005.10.044","article-title":"On the use of the Weibull function for the discernment of drug release mechanisms","volume":"309","author":"Papadopoulou","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2013.12.004_b0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0168-3659(87)90034-4","article-title":"A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2013.12.004_b0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1208\/pt0804094","article-title":"Newborn pig skin as model membrane in in vitro drug permeation studies: a technical note","volume":"8","author":"Cilurzo","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2013.12.004_b0190","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1081\/DDC-100100984","article-title":"Permeation enhancers for transdermal drug delivery","volume":"26","author":"Sinha","year":"2000","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2013.12.004_b0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1567201052772915","article-title":"Transdermal drug delivery: penetration enhancement techniques","volume":"2","author":"Benson","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2013.12.004_b0200","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1208\/s12248-008-9012-0","article-title":"Percutaneous permeation enhancement by terpenes: mechanistic view","volume":"10","author":"Sapra","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2013.12.004_b0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/03639040802192822","article-title":"Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics","volume":"35","author":"Bhaskar","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2013.12.004_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-013-1993-7","article-title":"Design of a dual nanostructured lipid carrier formulation based on physicochemical, rheological, and mechanical properties","volume":"15","author":"Vitorino","year":"2013","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ejpb.2013.12.004_b0215","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1517\/17425241003663228","article-title":"Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin","volume":"7","author":"Milewski","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2013.12.004_b0220","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.addr.2007.07.004","article-title":"Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models","volume":"59","author":"Godin","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2013.12.004_b0225","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1461-5347(00)00295-9","article-title":"Transdermal drug delivery: overcoming the skin\u2019s barrier function","volume":"3","author":"Naik","year":"2000","journal-title":"Pharm. Sci. Technol. Today"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111300386X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111300386X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T23:32:00Z","timestamp":1597188720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964111300386X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S093964111300386X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.12.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: In vitro vs. in vivo studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}